129 related articles for article (PubMed ID: 3399005)
1. [Lipo prostaglandin E1 administration in the acute stage following subarachnoid hemorrhage].
Korosue K; Kondoh T; Ishikawa A; Suzuki H; Nagao T; Tamaki N; Matsumoto S
No Shinkei Geka; 1988; 16(5 Suppl):509-15. PubMed ID: 3399005
[TBL] [Abstract][Full Text] [Related]
2. [Clinical effects of lipo-prostaglandin E1 in patients with delayed cerebral vasospasm].
Korosue K; Izawa I; Hamano S; Ishida K; Kurihara E; Nagao T; Tamaki N; Matsumoto S
No Shinkei Geka; 1987 Jun; 15(6):635-40. PubMed ID: 3670536
[TBL] [Abstract][Full Text] [Related]
3. [Clinical and hemodynamic effects of lipo PGE1 in cerebral infarction].
Korosue K; Kondoh T; Ishikawa A; Suzuki H; Nagao T; Tamaki N; Matsumoto S
No Shinkei Geka; 1988 Jun; 16(7):819-26. PubMed ID: 3221965
[TBL] [Abstract][Full Text] [Related]
4. Cerebral blood flow in patients with a subarachnoid haemorrhage during treatment with tranexamic acid.
Tsementzis SA; Meyer CH; Hitchcock ER
Neurochirurgia (Stuttg); 1992 May; 35(3):74-8. PubMed ID: 1603224
[TBL] [Abstract][Full Text] [Related]
5. Beneficial effects of intravenous administration of lipo-prostaglandin E1 on the ischemic gastric tube in pigs.
Tobari S; Ikeda Y; Takami H
J Surg Res; 2005 Nov; 129(1):79-84. PubMed ID: 16087193
[TBL] [Abstract][Full Text] [Related]
6. [Intracavernous injection of lipo prostaglandin E1 for the diagnosis of impotence: a comparative study with prostaglandin E1-CD].
Yajima M; Baba K; Minagawa N; Kohno S; Haraguchi C; Iwamoto T; Osada T
Hinyokika Kiyo; 1993 Mar; 39(3):289-92. PubMed ID: 8506803
[TBL] [Abstract][Full Text] [Related]
7. Prostaglandin E1 in lipid microspheres ameliorates diabetic peripheral neuropathy: clinical usefulness of Semmes-Weinstein monofilaments for evaluating diabetic sensory abnormality.
Akahori H; Takamura T; Hayakawa T; Ando H; Yamashita H; Kobayashi K
Diabetes Res Clin Pract; 2004 Jun; 64(3):153-9. PubMed ID: 15126001
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial of intraoperative, intracisternal tissue plasminogen activator for the prevention of vasospasm.
Findlay JM; Kassell NF; Weir BK; Haley EC; Kongable G; Germanson T; Truskowski L; Alves WM; Holness RO; Knuckey NW
Neurosurgery; 1995 Jul; 37(1):168-76; discussion 177-8. PubMed ID: 8587685
[TBL] [Abstract][Full Text] [Related]
9. [Effects of an intravenous injection of nicardipine on cerebral blood flow in subarachnoid hemorrhage caused by intracranial aneurysm].
Montarry M; Chacornac R; Philippon B; Bouchet C; Guichard P
Agressologie; 1989 Jun; 30(7):411-5. PubMed ID: 2817238
[TBL] [Abstract][Full Text] [Related]
10. [Effects of traumatic subarachnoid hemorrhage on pathological properties in diffuse brain injury: a comparison with aneurysmal subarachnoid hemorrhage].
Fukuda T; Mikoshiba M; Fukushima C; Nishi T; Nakajima S; Hasue M; Ikeda K; Sengoku Y; Ito H
No Shinkei Geka; 1996 Aug; 24(8):723-31. PubMed ID: 8741407
[TBL] [Abstract][Full Text] [Related]
11. Admission angiographic cerebral circulation time may predict subsequent angiographic vasospasm after aneurysmal subarachnoid hemorrhage.
Udoetuk JD; Stiefel MF; Hurst RW; Weigele JB; LeRoux PD
Neurosurgery; 2007 Dec; 61(6):1152-9; discussion 1159-61. PubMed ID: 18162893
[TBL] [Abstract][Full Text] [Related]
12. A multicenter double blind controlled study of lipo-PGE1, PGE1 incorporated in lipid microspheres, in peripheral vascular disease secondary to connective tissue disorders.
Mizushima Y; Shiokawa Y; Homma M; Kashiwazaki S; Ichikawa Y; Hashimoto H; Sakuma A
J Rheumatol; 1987 Feb; 14(1):97-101. PubMed ID: 3553591
[TBL] [Abstract][Full Text] [Related]
13. [Effects of controlled hypotension induced by prostaglandin E1 on the cerebral blood flow].
Sha K; Miyata Y; Nagahata T; Hashizume K; Ueda Y; Hiraki N
Masui; 1990 Feb; 39(2):138-43. PubMed ID: 2325248
[TBL] [Abstract][Full Text] [Related]
14. Randomized control trial of lipo-prostaglandin E1 in patients with acute liver injury induced by lipiodol-targeted chemotherapy.
Ikegami T; Matsuzaki Y; Kurusu J; Yoshiga S; Saito Y; Chiba T; Abei M; Shoda J; Tanaka N; Osuga T
Clin Pharmacol Ther; 1995 May; 57(5):582-9. PubMed ID: 7768081
[TBL] [Abstract][Full Text] [Related]
15. Effects of iso- and hypervolemic hemodilution on regional cerebral blood flow and oxygen delivery for patients with vasospasm after aneurysmal subarachnoid hemorrhage.
Ekelund A; Reinstrup P; Ryding E; Andersson AM; Molund T; Kristiansson KA; Romner B; Brandt L; Säveland H
Acta Neurochir (Wien); 2002 Jul; 144(7):703-12; discussion 712-3. PubMed ID: 12181704
[TBL] [Abstract][Full Text] [Related]
16. Effects of lipo-prostaglandin E1 on wound bed microcirculation.
Hasegawa H; Ichioka S
J Wound Care; 2015 Jul; 24(7):293-4, 296, 298-9. PubMed ID: 26198551
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E1 incorporated in lipid microspheres (lipo PGE1).
Otomo S; Mizushima Y; Aihara H; Yokoyama K; Watanabe M; Yanagawa A
Drugs Exp Clin Res; 1985; 11(9):627-31. PubMed ID: 3880049
[TBL] [Abstract][Full Text] [Related]
18. Systemic administration of phosphodiesterase V inhibitor, sildenafil citrate, for attenuation of cerebral vasospasm after experimental subarachnoid hemorrhage.
Atalay B; Caner H; Cekinmez M; Ozen O; Celasun B; Altinors N
Neurosurgery; 2006 Nov; 59(5):1102-7; discussion 1107-8. PubMed ID: 17143244
[TBL] [Abstract][Full Text] [Related]
19. Intravenous magnesium versus nimodipine in the treatment of patients with aneurysmal subarachnoid hemorrhage: a randomized study.
Schmid-Elsaesser R; Kunz M; Zausinger S; Prueckner S; Briegel J; Steiger HJ
Neurosurgery; 2006 Jun; 58(6):1054-65; discussion 1054-65. PubMed ID: 16723884
[TBL] [Abstract][Full Text] [Related]
20. Progress in the prostaglandin E1-therapy of the intermittent claudication by means of bolus injections of LIPO-prostaglandin E1 (LIPO-PGE1).
Scheffler P; Gross J; Markwirth T; Maier J; Schieffer H
Eur J Clin Pharmacol; 1996; 51(3-4):235-9. PubMed ID: 9010691
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
